We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+14.57%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$10.5B
AUM Growth
+$2.2B
Cap. Flow
+$1.93B
Cap. Flow %
18.42%
Top 10 Hldgs %
53.77%
Holding
422
New
188
Increased
50
Reduced
56
Closed
85

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$395M
2
COHR
Coherent Inc
COHR
+$266M
3
XLNX
Xilinx Inc
XLNX
+$242M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$216M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$205M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$704M
2
DD icon
DuPont de Nemours
DD
+$162M
3
IFF icon
International Flavors & Fragrances
IFF
+$92M
4
EV
Eaton Vance Corp.
EV
+$91.7M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$81M

Sector Composition

Rank Sector Weight
1 Healthcare 15.95%
2 Technology 13.98%
3 Communication Services 6%
4 Industrials 4.33%
5 Materials 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EV
401
DELISTED
Eaton Vance Corp.
EV
– –
-1,350,000
Closed -$91.7M
CBMG
402
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
– –
-110,000
Closed -$2.02M
VRTU
403
DELISTED
Virtusa Corporation
VRTU
– –
-188,000
Closed -$9.61M
EIGI
404
DELISTED
Endurance International Group Holdings, Inc.
EIGI
– –
-150,000
Closed -$1.42M
EIDX
405
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
– –
-121,933
Closed -$16M
PRVL
406
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
– –
-17,694
Closed -$408K
CXO
407
DELISTED
CONCHO RESOURCES INC.
CXO
– –
-961,000
Closed -$56.1M
FIT
408
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-4,425,000
Closed -$30.1M
FIT
409
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-3,450,100
Closed -$23.5M
PE
410
DELISTED
PARSLEY ENERGY INC
PE
– –
-400,000
Closed -$5.68M
WPX
411
DELISTED
WPX Energy, Inc.
WPX
– –
-713,100
Closed -$5.81M
TIF
412
DELISTED
Tiffany & Co.
TIF
– –
-5,356,700
Closed -$704M
TIF
413
PUT
DELISTED
Tiffany & Co.
TIF
– –
-2,550,000
Closed -$335M
BMY.RT
414
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-69,050,000
Closed -$47.7M
BMCH
415
DELISTED
BMC Stock Holdings, Inc
BMCH
– –
-94,135
Closed -$5.05M
BEAT
416
DELISTED
BioTelemetry, Inc.
BEAT
– –
-30,000
Closed -$2.16M
RESI
417
DELISTED
Front Yard Residential Corporation Common Stock
RESI
– –
-440,000
Closed -$7.13M
13 14 15 16
17

Similar funds

CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Pentwater Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Pentwater Capital Management held 422 positions worth $10.5B, up 27% from $8.28B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Pentwater Capital Management deployed $1.93B of net new capital in Q1 2021, opening 188 new positions and adding to 50 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 2,102,104 shares worth $456M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 7.5% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $162M trimmed.

  • Pentwater Capital Management's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 2,102,104 shares worth $456M.
  • Pentwater Capital Management added most to Xilinx Inc in Q1 2021, an estimated $242M increase.
  • Pentwater Capital Management's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $162M.
  • Pentwater Capital Management fully exited Tiffany & Co. in Q1 2021, selling an estimated $704M.
  • Pentwater Capital Management's ten largest holdings make up 54% of its $10.5B portfolio in Q1 2021.
  • Pentwater Capital Management opened 188 new positions and closed 85 in Q1 2021.
  • Pentwater Capital Management's portfolio value rose 27% quarter-over-quarter to $10.5B.

Based on Pentwater Capital Management's 13F filing for Q1 2021, filed 17 May 2021.